To further confirm the enhanced antitumor efficacy of the Flagrp170-based chaperone vaccine, we immunized mice carrying Her2/neu-expressing mammary tumors with the Flagrp170-Her2/neu complex, Grp170-Her2/neu complex, or left them untreated. Here, HYOU1 is linked to breast cancer.